Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 8:34 AM ET

Media

Company Overview of Yeda Research and Development Company Ltd.

Company Overview

Yeda Research and Development Company Ltd., a technology transfer company, markets and commercializes intellectual properties that are created in the laboratories of Weizmann Institute of Science. The company identifies and assesses research projects with commercial potential, protects the intellectual property of the institute and its scientists, licenses the institute’s inventions and technologies to industry, and channels funding from industry to research projects. It markets and commercializes intellectual properties that cover a range of natural sciences, including biotechnology, pharmaceuticals, and diagnostics; bioinformatics, proteomics, biomatics, and system biology; medical devices...

Weizman Institue of Science

de Botton Building (Building No. 5)

P.O. Box 95

Rehovot,  76100

Israel

Founded in 1959

Phone:

972 8 947 0617

Fax:

972 8 947 0739

Key Executives for Yeda Research and Development Company Ltd.

Chief Executive Officer
Chief Financial Officer
Chief Intellectual Property Officer
Chif Business Officer
General Counsel
Compensation as of Fiscal Year 2015.

Yeda Research and Development Company Ltd. Key Developments

Sun Pharma Announces Research Collaboration with Yeda Research and Development Company Ltd. and Fundacion Ramón Domínguez

Sun Pharmaceutical Industries Ltd. entered into a tripartite research and option agreement with Weizmann Institute of Science and Spain's Health Research Institute of Santiago de Compostela (IDIS) to develop breakthrough products for the treatment of neurological diseases like brain stroke; as well as glioblastoma. Scientists at Weizmann Institute have developed a recombinant enzyme currently undergoing animal studies for indications of brain stroke and glioblastoma. Further studies of this enzyme will be conducted at the Health Research Institute of Santiago de Compostela in Spain. Moreover, this enzyme may potentially be indicated for uses beyond these two brain diseases. As per the signed triparty agreement, Sun Pharma will have the first right to develop these additional indications. Sun Pharma will have the exclusive option to conduct further development of the enzyme after completion of the preclinical studies. The company will have commercial rights to this product globally. It will also fund all future studies to be conducted on the enzyme. The tripartite research collaboration agreement has been signed between Sun Pharma, Yeda Research & Development Company Ltd. and Fundacion Ramón Domínguez. Based on outcome of animal studies, Sun Pharma will have an option to exercise rights for further development and commercialization of the enzyme.

TxCell SA Enters into Exclusive Option Agreement with Yeda Research and Development

TxCell SA announced that it has entered into an exclusive option agreement with Yeda Research and Development Co. Ltd. Resulting from the exclusive option agreement, TxCell will gain exclusive access to a CAR-Treg patent for suppression of autoimmune and inflammatory diseases originated in the Weizmann Institute of Science laboratory of Professor Zelig Eshhar. The patent application under the option that TxCell has obtained covers redirected, genetically engineered T regulatory cells (CAR-Treg) and their use in suppression of autoimmune and inflammatory diseases. The option agreement grants TxCell until June 30, 2016 to opt-in at predefined terms.

Yeda Presents at BIO-Europe 2015, Nov-03-2015 02:50 PM

Yeda Presents at BIO-Europe 2015, Nov-03-2015 02:50 PM. Venue: Munich, Germany.

Similar Private Companies By Industry

Company Name Region
Talit Communications Ltd. Middle East/Africa
Serendipity Content and Holdings Ltd. Middle East/Africa
Micon Ltd. Middle East/Africa
Jasmine Group Middle East/Africa
Reshet Communications & Productions Ltd Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Yeda Research and Development Company Ltd., please visit www.yedarnd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.